30
Participants
Start Date
April 30, 2008
Primary Completion Date
December 31, 2008
Study Completion Date
June 30, 2009
Plasmodium falciparum Malaria Protein 010 (FMP010)
Vaccine antigen is a recombinant protein based on merozoite surface protein-1 (MSP-1) of FVO strain of Plasmodium falciparum, and adjuvant AS01B is a proprietary adjuvant of GSK
Rabipur
Rabipur is a licensed rabies vaccine.
Collaborators (2)
GlaxoSmithKline
INDUSTRY
United States Agency for International Development (USAID)
FED
Walter Reed Army Institute of Research (WRAIR)
FED
Kenya Medical Research Institute
OTHER
U.S. Army Medical Research and Development Command
FED